Parkinson’s Disease Patients Used as Unpaid Test Subjects in Tech Start-Up’s ‘Health Data Heist’ Sparks Outrage Over the Commodification of Suffering
In a disturbing new low for Silicon Valley ethics, leaked documents reveal that a major biotech firm has been running a covert program that uses low-income Parkinson’s disease patients as unpaid data harvesters for a new AI treatment algorithm. The program, disguised as a “wellness initiative,” requires participants to log their tremors, voice patterns, and daily pain levels through a proprietary smartphone app—only for the company to sell that raw, deeply personal neurological data to insurance firms and pharmaceutical advertisers. Critics are calling this the “downfall of empathy,” arguing that we have officially crossed the line from seeking cures to mining sickness for profit. “We are turning the desperate into dollar signs,” said Dr. Evelyn Cross, a medical ethics professor. “If we cannot protect the most vulnerable among us—those battling Parkinson’s disease—then we have surrendered our humanity completely.” The backlash has been swift, with patients’ rights groups calling for immediate federal regulation and demanding the company delete all collected data, as the hashtag #DontProfitFromMyShaking trends globally.